Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether Febuxostat could protect cardiovascular function of peritoneal dialysis patients by lowering serum uric acid.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shanghai 10th People's Hospital
NCT07116746 · Gout, Gouty Arthritis, and more
NCT06310967 · Hyperuricemia, Hypouricemia, Renal
NCT06859073 · Healthy Volunteers, Hyperuricemia
NCT07002762 · Hyperuricemia or Gout
NCT06966635 · Hyperuricemia or Gout, Nephrolithiasis
Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions